Mirae Asset Global ETFs Holdings’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$491K Buy
151,406
+36,275
+32% +$106K ﹤0.01% 2021
2026
Q1
$284K Buy
115,131
+6,584
+6% +$13.9K ﹤0.01% 2176
2025
Q4
$223K Buy
108,547
+68,219
+169% +$197K ﹤0.01% 2308
2025
Q3
$140K Sell
40,328
-7,087
-15% -$19.8K ﹤0.01% 2506
2025
Q2
$104K Sell
47,415
-121,307
-72% -$198K ﹤0.01% 2594
2025
Q1
$196K Sell
168,722
-7,981
-5% -$11.7K ﹤0.01% 2330
2024
Q4
$224K Buy
176,703
+4,736
+3% +$12.1K ﹤0.01% 2337
2024
Q3
$586K Sell
171,967
-33,171
-16% -$144K ﹤0.01% 1841
2024
Q2
$959K Buy
+205,138
New +$1.16M ﹤0.01% 1478

Other funds holding EDIT

Mirae Asset Global ETFs Holdings's EDIT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Editas Medicine (EDIT) stake by 32% in Q2 2026, buying an estimated $106K and bringing the position to 151,406 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Mirae Asset Global ETFs Holdings first reported a position in EDIT in Q2 2024 and has held it in 9 quarters since. The position peaked at $959K in Q2 2024. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 151,406 shares of Editas Medicine worth $491K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 36,275 Editas Medicine shares in Q2 2026, an estimated $106K.
  • Editas Medicine made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2021 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Editas Medicine in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Editas Medicine position peaked at $959K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.